The China FOF Alliance recognizes WI Harper Group as “Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus”

[vc_row][vc_column][vc_column_text]WI Harper Group | 2020-03-09[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space height=”40px”][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1583943706688{background-color: #e5e5e5 !important;}”]On March 8th, the 2020 China Equity Investment Industry Conference was held in the form of online live broadcasting with support from China Venture Capital Co., the China FOF Alliance, and the China FOF Research Institute. The conference acknowledged and awarded WI Harper Group the Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]On March 8th, the 2020 China Equity Investment Industry Conference was held in the form of online live broadcasting with support from China Venture Capital Co., the China FOF Alliance, and the China FOF Research Institute. Representatives from government agencies, industry associations, FOF institutions, family offices and news media held a cloud dialogue to discuss the evolution and innovation of China’s equity investment industry.[/vc_column_text][vc_column_text]The conference released “China FOF 100 Index Report” and “China FOF Industry Under the Outbreak of Difficulties and Problems Investigation Report”, and launched the Chinese equity investment industry “LPGP”. The conference acknowledged Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus and 2020 China’s Outstanding Female Investors. WI Harper Group was awarded the Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus.

[/vc_column_text][vc_column_text]Founded in 1993, WI Harper Group is a pioneering cross-border venture capital firm investing in early to growth-stage companies across the US, Greater China, and the Asia Pacific. The Company focuses on investing in innovative projects at the forefront of science and technology worldwide, focusing on areas such as enterprise intelligence, sustainability and healthcare. It currently has offices in San Francisco, Beijing, and Taipei. Investment fields include high-tech (TMT) and healthcare, with a total investment of more than 400 companies, creating more than 100 successful cases of listing and merger exit. Successful investment portfolio includes Creative Labs, DivX, Vizio, SiRF and Commerce One and dozens of capital market companies listed on the Nasdaq and worldwide.WI Harper has also successfully invested in many of  China’s enterprises, including Sinovation Ventures, Xinwei Telecom, Focus Media, 21 Vianet, Merit Interactive, AdMaster, IKang, Edan Instruments, and MedicalSystem Technology.[/vc_column_text][vc_column_text]WI Harper Group and its portfolio companies are also actively contributing to the society in the battle against the coronavirus. For example, the electrocardiograph of Edan Instruments, the ventilators other medical equipment from Resvent Medical and Aeonmed, and the ICU System of MedicalSystem Technology have been put into use in the designated hospitals for the treatment of pneumonia. Kindstar Global became the designated unit for the novel coronavirus nucleic acid testing, and LabTech also released the virus nucleic acid testing laboratory solution. RongCloud, Ikang, Histo Medical, LinkedSee, Merit Interactive, Infinite Intelligent Pharma, and other enterprises are supporting the battle by their remote consultation, medical cloud services, big data, and AI + drug R & D.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]This recognition is a strong affirmation of WI Harper’s investment strategy and social impact during uncertain economic times. WI Harper Group, an early-stage venture capital fund with 27 years of history, was able to navigate the economic ups-and-downs during the 2004 SARS epidemic. As such, WI Harper Group continues to invest into innovative projects at the forefront of science and technology, while its portfolio companies continue to drive value to their local communities.[/vc_column_text][/vc_column][/vc_row]

The China FOF Alliance recognizes WI Harper Group as “Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus”

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.